NERV Stock Snapshot
Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.95
Market Cap
$217M
P/E (TTM)
-0.1
EPS (TTM)
$-34.67
Revenue (TTM)
$0
Div Yield
—
ROE
339.5%
Debt/Equity
—
52W Range
$2 – $12
NERV Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
Moving averages & overlays
Volume
Oscillators
Momentum & trend
Configure
10-Year Performance
Revenue, net income, margins and EPS trends
Revenue & Net Income$0
2017-12-31→2024-12-31
EPS$-34.67
2019-12-31→2025-12-31
Free Cash Flow—
2017-12-31→2017-12-31
Margins—
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NERV
Peer Median
P/E (TTM)
-0.1
—
P/B
-1.5
1.4
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NERV
Peer Median
ROA
-434.3%
-58.9%
ROE
339.5%
-83.3%
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NERV
Peer Median
Current Ratio
36.3
8.5
Quick Ratio
35.9
—
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NERV
Peer Median
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
NERV
Peer Median
EPS (Diluted)
$-34.67
—
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NERV
Peer Median
NERV Analyst Consensus
Bullish and bearish analyst opinions, 12-month price target, upside
BUY9 analysts
Strong Buy
222.2%
Buy
444.4%
Hold
333.3%
Sell
00.0%
Strong Sell
00.0%
12-Month Price Target
3 analysts
· 2026-08-19
Median$10.00
← Below all targets
$4.95
Low$7.00
High$14.00
Median target$10.00
+102.2%
Mean target$10.33
+109.0%
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.19%
Period
EPS Actual
EPS Est
Surprise
June 30, 2026
$-0.17
$-0.12
-0.05%
March 31, 2026
$-0.17
$-0.13
-0.04%
Dec. 31, 2025
$-0.64
$-0.31
-0.33%
June 30, 2025
$-0.43
$-0.92
0.49%
March 31, 2025
$-0.50
$-1.09
0.59%
Dec. 31, 2024
$-0.56
$-1.07
0.51%
Peer comparison (GICS sub-industry)
Key metrics vs sector peers
Ticker
Market Cap
P/E
Rev YoY
Net Margin
ROE
Gross Margin
NERV
$174M
-0.1
—
—
339.5%
—
ORGO
$658M
34.5
17.0%
6.6%
13.9%
—
AKBA
$427M
-80.5
47.5%
-2.3%
-17.3%
—
DTIL
$100M
-1.2
-50.1%
-133.4%
-72.4%
—
TARA
$286M
-4.0
—
—
-33.7%
—
RNA
$10.91B
-14.5
72.1%
-3650.4%
-47.5%
—
CNXU
—
—
—
—
—
—
IMUX
—
-0.9
—
—
—
—
TNXP
$200M
-1.1
29.8%
-946.2%
-60.0%
—
NBP
—
—
—
—
—
—
ABOS
$128M
-1.1
—
—
-129.4%
—
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
Income Statement14
Annual Income Statement data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
·
$0
$0
$0
·
$41M
$0
$0
$0
R&D Expense
$6M
$12M
$13M
$15M
$32M
$22M
$58M
$35M
$30M
SG&A Expense
$9M
$10M
$10M
$11M
$13M
$17M
$18M
$17M
$11M
Operating Expenses
$15M
$22M
$23M
$25M
$45M
$39M
$76M
$52M
$41M
Operating Income
$-15M
$-22M
$-23M
$-25M
$-45M
$2M
$-76M
$-52M
$-41M
Interest Income
$948.1K
$1M
$1M
$556.9K
$16.5K
$161.2K
$1M
$2M
$941.8K
Pretax Income
·
·
·
$-32M
$-52M
$2M
$-74M
$-50M
$-41M
Income Tax
·
·
·
·
$-2M
·
$-2M
$0
$-9M
Net Income
$-293M
$1M
$-30M
$-32M
$-50M
$2M
$-72M
$-50M
$-32M
EPS (Basic)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
EPS (Diluted)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
Shares (Basic)
8,463,581
7,568,981
6,506,372
5,340,194
5,340,196
40,823,717
39,014,302
·
·
Shares (Diluted)
8,463,581
7,573,763
6,506,372
5,340,194
5,340,196
40,916,871
39,014,302
·
·
EBITDA
$-15M
·
·
·
$-45M
$2M
$-76M
$-52M
$-41M
Balance Sheet22
Annual Balance Sheet data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Cash & Equivalents
$82M
$21M
$41M
$36M
$61M
$25M
$21M
$50M
$26M
Short-term Investments
·
·
·
·
·
·
$24M
$38M
$102M
Prepaid Expense
$697.7K
$806.9K
$989.9K
$848.1K
$1M
$2M
$1M
$2M
$1M
Current Assets
$83M
$22M
$42M
$40M
$62M
$27M
$47M
$90M
$130M
PP&E (Net)
$0
$5.4K
$10.9K
$16.3K
·
·
$16.0K
$33.5K
$50.9K
Goodwill
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
Intangibles
·
·
·
·
·
$15M
$15M
$34M
$34M
Other Non-current Assets
·
·
·
·
·
$14.8K
$14.8K
$14.8K
$14.8K
Total Assets
$98M
$37M
$57M
$55M
$77M
$58M
$77M
$139M
$184M
Accounts Payable
$639.7K
$2M
$2M
$969.7K
$2M
$995.6K
$2M
$2M
$1M
Short-term Debt
·
·
·
·
·
·
·
·
$4M
Current Liabilities
$2M
$3M
$3M
$1M
$3M
$3M
$7M
$4M
$7M
Capital Leases
·
·
·
·
·
·
$111.2K
·
·
Deferred Tax
·
·
·
·
·
$2M
$2M
$4M
$4M
Other Non-current Liabilities
·
·
·
·
·
·
·
$29.0K
$29.9K
Total Liabilities
$234M
$63M
$85M
$75M
$69M
$5M
$50M
$49M
$52M
Total Debt
·
·
·
·
·
·
·
·
$4M
Common Stock
$4.3K
$699
$699
$534
$534
$4.3K
$3.9K
$3.9K
$3.9K
Retained Earnings
$-689M
$-395M
$-397M
$-367M
$-335M
$-285M
$-287M
$-215M
$-164M
Stockholders' Equity
$-141M
$-26M
$-28M
$-20M
$8M
$53M
$28M
$90M
$132M
Liabilities + Equity
$98M
$37M
$57M
$55M
$77M
$58M
$77M
$139M
$184M
Shares Outstanding
43,274,398
6,993,406
6,993,406
5,340,193
5,340,196
5,340,196
39,084,121
38,937,971
38,749,343
Cash Flow12
Annual Cash Flow data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
D&A
$5.4K
$5.4K
$5.4K
·
·
$16.0K
$17.5K
$17.5K
$11.1K
Stock-based Comp
$1M
$1M
$2M
$4M
$5M
$10M
$9M
$8M
$5M
Other Non-cash
·
·
·
·
·
$-45M
$20M
$29.4K
$30M
Operating Cash Flow
$-14M
$-20M
$-15M
$-25M
$-25M
$-34M
$-43M
$-42M
$3M
CapEx
·
·
·
$16.3K
·
·
·
·
$52.4K
Investing Cash Flow
$0
$0
$0
$-16.3K
·
$25M
$14M
$69M
$-107M
Stock Repurchased
·
·
·
·
·
·
·
·
$389
Net Stock Activity
·
·
·
·
·
·
·
·
$-389
Financing Cash Flow
$74M
·
$20M
$-5
$60M
$13M
$525.0K
$-3M
$47M
Net Change in Cash
$61M
$-20M
$5M
$-25M
$35M
$4M
$-29M
$24M
$-57M
Taxes Paid
$0
$0
·
·
·
·
·
·
·
Free Cash Flow
·
·
·
·
·
·
·
·
$3M
Profitability7
Annual Profitability data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Operating Margin
·
·
·
·
·
4.5%
·
·
·
Net Margin
·
·
·
·
·
4.7%
·
·
·
Pretax Margin
·
·
·
·
·
4.7%
·
·
·
EBITDA Margin
·
·
·
·
·
4.5%
·
·
·
ROA
-434.3%
·
·
·
-74.1%
2.9%
-66.6%
-31.1%
-19.9%
ROE
339.5%
·
·
·
-276.8%
3.5%
-173.3%
-52.3%
-24.1%
ROIC
·
·
·
·
-549.0%
·
-264.8%
-57.3%
-23.4%
Liquidity & Solvency3
Annual Liquidity & Solvency data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Current Ratio
36.3
·
·
·
22.1
8.7
7.1
24.9
18.9
Quick Ratio
35.9
·
·
·
21.6
8.0
6.9
24.4
18.7
Debt / Equity
·
·
·
·
·
·
·
·
0.0
Efficiency1
Annual Efficiency data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Asset Turnover
·
·
·
·
·
0.6
0.0
0.0
0.0
Per Share5
Annual Per Share data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Book Value / Share
$-3.25
·
·
·
$0.19
$1.23
$0.71
$2.32
$3.40
Revenue / Share
·
·
·
·
·
$1.01
·
·
·
Cash Flow / Share
$-1.60
·
·
·
$-0.58
$-0.83
·
·
·
Cash / Share
$1.90
·
·
·
$1.42
$0.59
$0.55
$1.29
$0.67
EPS (TTM)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
Valuation (TTM)13
Annual Valuation (TTM) data for NERV
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue TTM
·
$0
$0
$0
·
$41M
$0
$0
$0
Net Income TTM
$-293M
$1M
$-30M
$-32M
$-50M
$2M
$-72M
$-50M
$-32M
Market Cap
$174M
·
·
·
$274M
$800M
$2.22B
$2.10B
$1.88B
Enterprise Value
·
·
·
·
·
·
·
·
$1.75B
P/E
-0.1
11.7
-1.3
-0.3
-0.7
374.4
-30.7
·
·
P/S
·
·
·
·
·
19.4
·
·
·
P/B
-1.2
·
·
·
34.3
15.2
80.0
23.3
14.3
P / Tangible Book
·
·
·
·
·
35.4
·
·
·
P / Cash Flow
-12.9
·
·
·
-11.1
-23.6
-51.2
-50.1
606.4
P / FCF
·
·
·
·
·
·
·
·
616.8
EV / EBITDA
·
·
·
·
·
·
·
·
-42.5
EV / FCF
·
·
·
·
·
·
·
·
576.0
Earnings Yield
-862.4%
8.6%
-75.0%
-378.0%
-145.9%
0.27%
-3.2%
·
·
Income Statement11
Quarterly Income Statement data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
R&D Expense
$7M
$5M
$2M
$925.4K
$1M
$1M
$2M
$2M
$4M
$4M
$5M
$3M
$2M
$3M
$3M
$2M
SG&A Expense
$3M
$11M
$3M
$2M
$2M
$3M
$3M
$2M
$2M
$3M
$2M
$3M
$3M
$3M
$2M
$3M
Operating Expenses
$11M
$17M
$5M
$3M
$3M
$4M
$5M
$4M
$6M
$7M
$7M
$6M
$5M
$5M
$5M
$5M
Operating Income
$-11M
$-17M
$-5M
$-3M
$-3M
$-4M
$-5M
$-4M
$-6M
$-7M
$-7M
$-6M
$-5M
$-5M
$-5M
$-5M
Interest Income
$569.6K
$629.6K
$546.5K
$106.6K
$136.7K
$158.3K
$239.7K
$314.0K
$360.8K
$357.9K
$358.9K
$348.7K
$365.6K
$364.2K
$297.1K
$180.1K
Net Income
$17M
$-125M
$-284M
$-3M
$-3M
$-4M
$-4M
$23M
$-8M
$-9M
$-9M
$-8M
$-6M
$-7M
$-7M
$-7M
EPS (Basic)
$0.36
$-2.86
$-33.38
$-0.36
$-0.43
$-0.50
$-0.56
$2.97
$-1.09
$-1.13
$-1.15
$-1.03
$-1.12
$-1.31
$-1.26
$-1.29
EPS (Diluted)
$-0.14
$-2.86
$-33.38
$-0.36
$-0.43
$-0.50
$-0.56
$2.97
$-1.09
$-1.13
$-1.15
$-1.03
$-1.12
$-1.31
$-1.26
$-1.29
Shares (Basic)
46,599,044
43,900,426
-14,243,362
7,568,981
7,568,981
7,568,981
-15,137,962
7,568,981
7,568,981
7,568,981
-11,913,965
7,568,981
5,511,163
5,340,193
-10,680,391
5,340,193
Shares (Diluted)
79,104,585
43,900,426
-14,243,362
7,568,981
7,568,981
7,568,981
-15,133,180
7,568,981
7,568,981
7,568,981
-11,913,965
7,568,981
5,511,163
5,340,193
-10,680,391
5,340,193
EBITDA
$-11M
$-17M
·
$-3M
$-3M
$-4M
·
$-4M
$-6M
$-7M
·
$-6M
$-5M
$-5M
·
$-5M
Balance Sheet15
Quarterly Balance Sheet data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$25M
$33M
$82M
$12M
$15M
$17M
$21M
$27M
$31M
$35M
$41M
$47M
$52M
$36M
$36M
$40M
Short-term Investments
$51M
$45M
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Prepaid Expense
$4M
$941.9K
$697.7K
$633.5K
$199.6K
$534.8K
$806.9K
$1M
$428.0K
$702.5K
$989.9K
$1M
$329.2K
$596.0K
$848.1K
$1M
Current Assets
$80M
$79M
$83M
$13M
$16M
$18M
$22M
$28M
$31M
$36M
$42M
$48M
$52M
$37M
$40M
$45M
PP&E (Net)
·
·
$0
$1.4K
$2.7K
$4.1K
$5.4K
$6.8K
$8.2K
$9.5K
$10.9K
$12.2K
$13.6K
$15.0K
$16.3K
·
Goodwill
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
Total Assets
$95M
$94M
$98M
$28M
$30M
$33M
$37M
$43M
$46M
$51M
$57M
$63M
$67M
$52M
$55M
$60M
Accounts Payable
$1M
$2M
$639.7K
$944.5K
$896.8K
$639.9K
$2M
$553.2K
$828.3K
$1M
$2M
$1M
$298.3K
$961.0K
$969.7K
$532.9K
Current Liabilities
$4M
$4M
$2M
$3M
$3M
$2M
$3M
$4M
$4M
$3M
$3M
$3M
$2M
$3M
$1M
$2M
Total Liabilities
$297M
$343M
$234M
$63M
$63M
$62M
$63M
$64M
$91M
$87M
$85M
$83M
$80M
$78M
$75M
$74M
Common Stock
$4.7K
$4.4K
$4.3K
$699
$699
$699
$699
$699
$699
$699
$699
$699
$699
$534
$534
$534
Retained Earnings
$-797M
$-814M
$-689M
$-405M
$-402M
$-399M
$-395M
$-391M
$-414M
$-405M
$-397M
$-388M
$-380M
$-374M
$-367M
$-360M
Stockholders' Equity
$-213M
$-254M
$-141M
$-35M
$-32M
$-29M
$-26M
$-22M
$-44M
$-37M
$-28M
$-20M
$-13M
$-27M
$-20M
$-14M
Liabilities + Equity
$95M
$94M
$98M
$28M
$30M
$33M
$37M
$43M
$46M
$51M
$57M
$63M
$67M
$52M
$55M
$60M
Shares Outstanding
47,227,259
43,841,998
43,274,398
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
5,340,193
5,340,193
5,340,193
Cash Flow6
Quarterly Cash Flow data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
D&A
·
·
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
·
·
Stock-based Comp
$2M
$9M
$459.0K
$272.9K
$298.2K
$297.2K
$249.7K
$307.7K
$329.3K
$438.8K
$611.1K
$371.9K
$608.9K
$376.5K
$947.7K
$1M
Operating Cash Flow
$-13M
$-5M
$-4M
$-3M
$-2M
$-4M
$-5M
$-4M
$-4M
$-6M
$-6M
$-5M
$-4M
$-115.4K
$-4M
$-10M
Investing Cash Flow
$-5M
$-45M
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$-16.3K
·
Financing Cash Flow
$10M
$1M
$74M
$-45.2K
$0
$0
·
·
$0
$0
$0
$-86.7K
$20M
$0
$0
$0
Net Change in Cash
$-8M
$-50M
$70M
$-3M
$-2M
$-4M
$-5M
$-4M
$-4M
$-6M
$-6M
$-5M
$16M
$-115.4K
$-4M
$-10M
Profitability2
Quarterly Profitability data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
ROA
27.8%
-197.8%
·
-7.7%
-8.5%
-9.0%
·
42.5%
-14.5%
-16.8%
·
-12.7%
-9.4%
-11.4%
·
-8.8%
ROE
-14.2%
88.6%
·
9.8%
8.5%
11.4%
·
-107.9%
28.9%
27.1%
·
45.6%
59.3%
51.0%
·
-99.8%
Liquidity & Solvency2
Quarterly Liquidity & Solvency data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
20.1
17.6
·
4.9
6.1
9.2
·
6.2
7.5
12.6
·
14.4
27.4
14.7
·
20.4
Quick Ratio
19.0
17.4
·
4.6
6.0
8.9
·
5.9
7.3
12.3
·
14.0
27.1
14.4
·
18.3
Per Share4
Quarterly Per Share data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
$-4.52
$-5.79
·
$-4.94
$-4.59
$-4.17
·
$-3.10
$-6.36
$-5.23
·
$-2.87
$-1.79
$-4.98
·
$-2.67
Cash Flow / Share
·
$-0.12
·
·
·
$-0.54
·
·
·
$-0.81
·
·
·
$-0.02
·
·
Cash / Share
$0.52
$0.74
·
$1.76
$2.18
$2.47
·
$3.79
$4.42
$4.98
·
$6.71
$7.41
$6.74
·
$7.53
EPS (TTM)
$-3.79
$-4.15
·
$1.68
$0.95
$0.25
·
$-0.28
$-4.37
$-4.59
·
$-4.75
$-5.35
$-6.06
·
$-6.47
Valuation (TTM)6
Quarterly Valuation (TTM) data for NERV
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Net Income TTM
$-114M
$-135M
·
$13M
$7M
$2M
·
$-2M
$-31M
$-30M
·
$-28M
$-29M
$-32M
·
$-35M
Market Cap
$262M
$264M
·
$15M
$12M
$12M
·
$19M
$22M
$18M
·
$48M
$64M
$9M
·
$49M
P/E
-1.5
-1.5
·
1.3
1.8
6.8
·
-9.5
-0.7
-0.6
·
-1.5
-1.7
-0.3
·
-1.4
P/B
-1.2
-1.0
·
-0.4
-0.4
-0.4
·
-0.9
-0.5
-0.5
·
-2.4
-5.1
-0.3
·
-3.5
P / Cash Flow
·
-48.7
·
·
·
-2.9
·
·
·
-3.0
·
·
·
-74.0
·
·
Earnings Yield
-68.3%
-68.9%
·
79.8%
55.2%
14.7%
·
-10.5%
-137.0%
-177.9%
·
-68.8%
-58.5%
-378.8%
·
-70.1%
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
—
$0
$0
$0
—
Net Income
$-293M
$1M
$-30M
$-32M
$-50M
Diluted EPS
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
Balance Sheet
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Current Ratio
36.3
—
—
—
22.1
Quick Ratio
35.9
—
—
—
21.6
My Metrics
Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F)
60 filers · $216.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
27
(+9 vs prior Q)
8
(+5 vs prior Q)
10
(+2 vs prior Q)
11
(+3 vs prior Q)
-1.3M
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners
5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Filer
Filed
Stake
Status
Purpose
Filing
Boehringer AG, Boehringer Ingelheim International GmbH
×2 filings
INDEX VENTURE ASSOCIATES III LIMITED, INDEX VENTURES III (JERSEY) L.P., INDEX VENTURES III (DELAWARE) L.P., INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES IV LIMITED, INDEX VENTURES IV (JERSEY) L.P., INDEX VENTURES IV PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES V LIMITED, INDEX VENTURES V (JERSEY) L.P., INDEX VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., YUCCA (JERSEY) SLP
×5 filings
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership
Held by 11 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.